The European orthopedic biomaterials markets are expected to approach € 1 billion by 2017, with hyaluronic acid viscosupplementation as the largest segment.
The European orthopedic biomaterials markets include:
The European markets include:
The ACI market grew most rapidly in 2010 at a rate of nearly 12%, followed by the BGS market. Within the European orthopedic biomaterials market, companies such as Fidia, Genzyme, Rottapharm/Madaus and Smith & Nephew lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
The executive summary of this report is also available for purchase.
Browse more Orthopedic Market Research Reports